Major Rating Factors:
Poor long-term capitalization index (0.9 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (1.8) that places pressure on both capital and profits. In four of the last five years reserves (two year development) were between 46% and 612% deficient.
Other Rating Factors:
Weak profitability index (0.2) with operating losses during 2022. Weak overall results on stability tests (0.3) including weak results on operational trends and weak risk adjusted capital in prior years. Good liquidity (6.8) with sufficient resources (cash flows and marketable investments) to handle a spike in claims.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
NY
Principal Investments:
Investment grade bonds (78.4%), common stock (11.3%), cash (3.4%), preferred stock (1.2%), other (5.7%)